NCT00824746 - Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

December 31, 2011

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

Gefitinib retreatment

phase II trial of Gefitinib retreatment for the advanced or metastatic (IIIb and IV) NSCLC patients who previously responded to gefitinib And progressive disease should be observed with at least one prior regimen following previous EGFR-TKI failure.

Trial Locations (1)

519-809

Chonnam National University Hwasun Hospital, Hwasun-gun